# Bleomycin Jet Injections in Keloids

> **NCT04582305** · PHASE4 · UNKNOWN · sponsor: **Erasmus Medical Center** · enrollment: 14 (actual)

## Conditions studied

- Keloid

## Interventions

- **DRUG:** Bleomycin
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT04582305
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-18
- **Primary completion:** 2022-11-18
- **Final completion:** 2023-03-30
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2022-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04582305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04582305, "Bleomycin Jet Injections in Keloids". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04582305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*